Epidemiology of meningococcal disease in Latin America: current situation and opportunities for prevention
- 1 April 2010
- journal article
- Published by Taylor & Francis in Neurological Research
- Vol. 32 (3) , 263-271
- https://doi.org/10.1179/016164110x12644252260754
Abstract
Meningococcal disease continues to be a serious public health concern, being associated with high morbidity and mortality rates in many countries from Latin America. In addition to discussing recent changes in the epidemiology of meningococcal disease in the region, we also analyse the development and potential impact of new vaccines on the prevention of meningococcal disease. MEDLINE, SciELO, LILACS and websites of the national Ministries of Health databases were searched using the terms meningococcal disease, meningococcal epidemiology, Neisseria meningitidis, meningococcal vaccines and the name of Latin America countries, from 1998 to 2008, with emphasis on review articles, clinical trials and epidemiological studies. Epidemiology of meningococcal disease in Latin America is characterized by marked differences from country to country. The overall incidence of meningococcal disease per year varied from less than 0.1 cases per 100,000 inhabitants in countries like Mexico to two cases per 100,000 inhabitants in Brazil. The highest age-specific incidence of meningococcal disease occurred in infants less than 1 year of age. Serogroups B and C were responsible for the majority of cases reported, but the emergence of serogroups W135 and Y was reported in some countries. Serogroup A disease is now rare in Latin America. Although a few countries have established meningitis surveillance programs, the information is not uniform, and the quality of the reported data is poor in the majority of the region. The availability of new effective meningococcal conjugate vaccines and promising protein-based vaccine candidates against meningococcus B highlights the importance of a better understanding of the true burden of meningococcal disease in Latin America and also the need for cost-effectiveness studies before incorporating the new meningococcal vaccines to national immunization programs.Keywords
This publication has 25 references indexed in Scilit:
- Serogroup Y Meningococcal Disease, ColombiaEmerging Infectious Diseases, 2008
- PorA types in Neisseria meningitidis serogroup B isolated in Argentina from 2001 to 2003: implications for the design of an outer membrane protein-based vaccineJournal of Medical Microbiology, 2008
- Recognition of the epidemiological significance of Neisseria meningitidis capsular serogroup W135 in the Rio de Janeiro region, BrazilMemórias do Instituto Oswaldo Cruz, 2007
- PorA Variable Antigenic Regions VR1, VR2, and VR3 of Neisseria meningitidis Serogroups B and C Isolated in Brazil from 1999 to 2004Infection and Immunity, 2007
- Clonal Distribution of Invasive Neisseria meningitidis Serogroup C Strains Circulating from 1976 to 2005 in Greater São Paulo, BrazilJournal of Clinical Microbiology, 2007
- Phenotypic characterization of Neisseria meningitidis strains isolated from invasive disease in Brazil from 1990 to 2001Journal of Medical Microbiology, 2006
- Relative efficacy of different immunization schedules for the prevention of serogroup C meningococcal disease: A model-based evaluationVaccine, 2006
- Molecular analysis of anti-N-propionyl Neisseria meningitidis group B polysaccharide monoclonal antibodiesMolecular Immunology, 2006
- Meningococcal disease: History, epidemiology, pathogenesis, clinical manifestations, diagnosis, antimicrobial susceptibility and preventionIndian Journal of Medical Microbiology, 2006
- Complications of Meningococcal Disease in College StudentsClinical Infectious Diseases, 2001